Rentschler Group

Rentschler Biopharma is a leading global contract development and manufacturing organization (CDMO) focused exclusively on biopharmaceuticals. The company provides end-to-end solutions from process development and clinical supply to large-scale commercial manufacturing of complex biologics, including monoclonal antibodies and recombinant proteins. Headquartered in Laupheim, Germany, Rentschler has expanded its capabilities into advanced therapy medicinal products (ATMPs) such as viral vectors and mRNA through its specialized sites in Stevenage, UK, and Milford, MA. As a family-owned enterprise with a history spanning over 150 years, it is recognized for its high-quality standards and strategic partnerships across the global life sciences industry.